Kliniske forsøg med BCR prostatakarcinom
I alt 30488 resultater
-
Telix Pharmaceuticals (Innovations) Pty LimitedGrand Pharmaceutical (China) Co., Ltd.RekrutteringProstatakræft | Biokemisk gentagelse af ondartet neoplasma i prostata | BCR prostatakarcinomKina
-
University of WashingtonNational Cancer Institute (NCI)AfsluttetMetastatisk prostatakarcinom | Tilbagevendende prostatakarcinom | Hormon-resistent prostatakræft | Stadie IV Prostata AdenocarcinomForenede Stater
-
University of WashingtonNational Cancer Institute (NCI)AfsluttetKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Tilbagevendende prostatakarcinom | Kastrationsniveauer af testosteron | Stadie IV Prostata AdenocarcinomForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)AfsluttetProstata Adenocarcinom | Prostata karcinom | Tilbagevendende prostatakarcinom | Stadie III prostatakræft | Stadie IV prostatakræftForenede Stater
-
Andrei IagaruAfsluttetProstata Adenocarcinom | Tilbagevendende prostatakarcinom | PSA-fejlForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetLymfadenopati | Kastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Prostata Adenocarcinom | Kastrationsniveauer af testosteron | Prostatakarcinom Metastatisk i knoglerne | Prostata småcellet karcinomForenede Stater
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science UniversityAfsluttetKastrationsresistent prostatakarcinom | Prostata Adenocarcinom | Tilbagevendende prostatakarcinom | Stadie IV prostatakræft | PSA Progression | Kastrationsniveauer af testosteronForenede Stater
-
Jonsson Comprehensive Cancer CenterAfsluttetProstata Adenocarcinom | Tilbagevendende prostatakarcinomForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeMetastatisk prostatakarcinom | Prostata Adenocarcinom | Tilbagevendende prostatakarcinom | Hormon-resistent prostatakræftForenede Stater
-
ValiRx PlcAfsluttetStadie III prostatakarcinom | Stage IV Prostate Carcinoma
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeStadie II Prostata Adenocarcinom | Stadie III Prostata Adenocarcinom | Stadie I Prostata AdenocarcinomForenede Stater, Canada, Puerto Rico
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)AfsluttetStadie II Prostata Adenocarcinom | Stadie III Prostata Adenocarcinom | Stadie I Prostata AdenocarcinomForenede Stater
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyAfsluttetMetastatisk prostatakarcinom | Metastatisk prostataadenokarcinom | Prostatakarcinom Metastaserende til knoglerneForenede Stater
-
Rigshospitalet, DenmarkAfsluttet
-
Shanghai Proton and Heavy Ion CenterUkendtMetastatisk prostatakarcinomKina
-
University of California, San FranciscoIkke rekrutterer endnuProstata Adenocarcinom | Lokaliseret prostatakarcinomForenede Stater
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RekrutteringProstata Adenocarcinom | Lokaliseret prostatakarcinomForenede Stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Stadie IV Prostata Adenocarcinom AJCC v7 | Avanceret prostataadenokarcinom med neuroendokrin differentiering | Metastatisk prostataadenokarcinom med neuroendokrin differentiering | Prostata Adenocarcinom med neuroendokrin differentieringForenede Stater
-
Mayo ClinicRekrutteringProstata Adenocarcinom | Oligometastatisk prostatacarcinomForenede Stater
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Trukket tilbageKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Stadie IV prostatakræft
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)AfsluttetKastrationsresistent prostatakarcinom | PSA Progression | Stadie IV Prostata Adenocarcinom AJCC v7 | Kastrationsniveauer af testosteron | Prostatakarcinom Metastatisk i knoglerneForenede Stater
-
University of WashingtonNational Cancer Institute (NCI); AstraZenecaAfsluttetKastrationsresistent prostatakarcinom | Prostata AdenocarcinomForenede Stater
-
University of California, San FranciscoAfsluttetProstata Adenocarcinom | Tilbagevendende prostatakarcinom | Stadie III Prostata Adenocarcinom AJCC v7 | Stadie I Prostata Adenocarcinom AJCC v7 | Stadie II Prostata Adenocarcinom AJCC v7Forenede Stater
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RekrutteringBiokemisk tilbagevendende prostatakarcinom | Metastatisk prostatakarcinom | Prostata Adenocarcinom | Stadie IVB prostatakræft AJCC v8Forenede Stater
-
University of UtahAfsluttetMetastatisk prostatakarcinom | Stadie IV prostatakræft | Prostatakarcinom Metastatisk i knoglerneForenede Stater
-
University of WashingtonRekrutteringBiokemisk tilbagevendende prostatakarcinom | Kastrationsresistent prostatakarcinom | Prostata Adenocarcinom | Fase IV prostatakræft AJCC v8Forenede Stater
-
Hongqian GuoAstraZeneca; Nanjing Chia-tai Tianqing PharmaceuticalRekrutteringProstatakræft | Metastatisk prostatakræft | Prostata karcinomKina
-
Emory UniversityAfsluttetKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Fase IV prostatakræft AJCC v7Forenede Stater
-
Case Comprehensive Cancer CenterAfsluttetAdenocarcinom i prostata | Adenocarcinom i prostata Stadium I | Adenocarcinom i prostata Stadium II | Adenocarcinom i prostata Stadium IIIForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)Trukket tilbageStadie II Prostata Adenocarcinom | Stadie I Prostata Adenocarcinom
-
Dana-Farber Cancer InstituteAfsluttetProstatakræft | Adenocarcinom i prostata Stadium I | Adenocarcinom i prostata Stadium II | Adenocarcinom i prostata Stadium IIIForenede Stater
-
Grupo de Investigación Clínica en Oncología RadioterapiaRekruttering
-
University Hospital, BrestAfsluttet
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cancer Immunotherapy Trials NetworkAfsluttetKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom | Stadie IV prostatakræft | Kastrationsniveauer af testosteronForenede Stater
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of Bologna; Catholic University of the Sacred Heart; Michigan... og andre samarbejdspartnereAfsluttet
-
Fundación Canaria de Investigación SanitariaHospital Universitario de CanariasUkendt
-
M.D. Anderson Cancer CenterAktiv, ikke rekrutterendeProstata Adenocarcinom | Tilbagevendende prostatakarcinomForenede Stater
-
Astellas Pharma Europe B.V.AfsluttetAvanceret prostatakarcinomDen Russiske Føderation
-
University of California, San FranciscoNational Cancer Institute (NCI)AfsluttetPSA Progression | Metastatisk prostatakarcinom i det bløde væv | Hormon-resistent prostatakræft | Stadie IV Prostata Adenocarcinom AJCC v7 | Kastrationsniveauer af testosteron | Prostatakarcinom Metastatisk i knoglerneForenede Stater
-
M.D. Anderson Cancer CenterRekrutteringBiokemisk tilbagevendende prostatakarcinom | Prostata Adenocarcinom | Lokaliseret prostatakarcinomForenede Stater
-
M.D. Anderson Cancer CenterCelgeneAfsluttet
-
VA Office of Research and DevelopmentSanofiAfsluttetProstatakræftForenede Stater, Puerto Rico
-
SCRI Development Innovations, LLCBristol-Myers SquibbAfsluttet
-
Royal Marsden NHS Foundation TrustIkke rekrutterer endnuAvanceret prostatakarcinomDet Forenede Kongerige
-
Stanford UniversityNational Cancer Institute (NCI)AfsluttetTilbagevendende prostatakarcinomForenede Stater
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRekrutteringProstatakræft | Prostata karcinom | Metastatisk kastrationsresistent prostatakræftKina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeKastrationsresistent prostatakarcinom | Metastatisk prostatakarcinom i det bløde væv | Stadie IV Prostata Adenocarcinom AJCC v7 | Kastrationsniveauer af testosteron | Prostatakarcinom Metastatisk i knoglerneForenede Stater, Puerto Rico
-
Emory UniversityNational Cancer Institute (NCI)RekrutteringBiokemisk tilbagevendende prostatakarcinom | Prostata AdenocarcinomForenede Stater
-
University of WashingtonJanssen Scientific Affairs, LLCRekrutteringKastrationsresistent prostatakarcinom | Prostata AdenocarcinomForenede Stater
-
Mayo ClinicNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeProstata Adenocarcinom | Fase IV prostatakræft AJCC v8 | Tilbagevendende prostatakarcinom | Metastatisk prostataadenokarcinom | Oligometastatisk prostatacarcinomForenede Stater